<code id='5028E13D60'></code><style id='5028E13D60'></style>
    • <acronym id='5028E13D60'></acronym>
      <center id='5028E13D60'><center id='5028E13D60'><tfoot id='5028E13D60'></tfoot></center><abbr id='5028E13D60'><dir id='5028E13D60'><tfoot id='5028E13D60'></tfoot><noframes id='5028E13D60'>

    • <optgroup id='5028E13D60'><strike id='5028E13D60'><sup id='5028E13D60'></sup></strike><code id='5028E13D60'></code></optgroup>
        1. <b id='5028E13D60'><label id='5028E13D60'><select id='5028E13D60'><dt id='5028E13D60'><span id='5028E13D60'></span></dt></select></label></b><u id='5028E13D60'></u>
          <i id='5028E13D60'><strike id='5028E13D60'><tt id='5028E13D60'><pre id='5028E13D60'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:7773
          Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT
          Molly Ferguson for STAT

          The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

          Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

          advertisement

          All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Why Talkspace is targeting Medicare, a tricky market
          Why Talkspace is targeting Medicare, a tricky market

          AdobeOverthelastfewyears,virtualmentalhealthcompanyTalkspacehasbeenonarelentlessquesttoconquertheins

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo